Satiety Innovation- Study 793. University of Aberdeen

NCT01724411 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2015-03-31

No results posted yet for this study

Summary

The proposed study will address the effect of developed novel food products through processing innovation on motivation to eat, biomarkers of satiety, nutrient bioavailability and gut health using in vivo studies and validating new in vivo approaches.

Specifically in this protocol we will address, in a short human intervention study the effect of a potentially satiating product on appetite, appetite biomarkers, particularly the influence on gut microbiota, tolerance and safety of the products in healthy obese and overweight volunteers in free living conditions.

Conditions

  • Overweight and Obesity

Interventions

OTHER

Resistant Starch type 3

Resistant Starch 3: 26g/day males for 11 days, 22 g/day females for 11 days

Sponsors & Collaborators

  • Københavns Universitet

    collaborator OTHER
  • University of Leeds

    collaborator OTHER
  • University of Liverpool

    collaborator OTHER
  • Universidad de Murcia

    collaborator OTHER
  • University Rovira i Virgili

    collaborator OTHER
  • Karolinska Institutet

    collaborator OTHER
  • Cargill

    collaborator INDUSTRY
  • The Coca-Cola Company

    collaborator INDUSTRY
  • Juver Alimentación S.L.U

    collaborator INDUSTRY
  • Naturex, Spain

    collaborator INDUSTRY
  • Axxam S.p.A.

    collaborator INDUSTRY
  • BioActor

    collaborator INDUSTRY
  • Centro Tecnológico Nacional Agroalimentario Extremadura

    collaborator OTHER
  • Centro Tecnológico Nacional de la Conserva y Alimentación

    collaborator OTHER
  • NIZO Food Research

    collaborator OTHER
  • RTD Services Vienna

    collaborator OTHER
  • ProDigest

    collaborator INDUSTRY
  • P Burns

    lead OTHER

Principal Investigators

  • Dr Alexandra M Johnstone, PhD · University of Aberdeen

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2013-09-30
Completion
2014-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01724411 on ClinicalTrials.gov